Suppr超能文献

等待名单和移植后结局:国际器官共享网络注册系统中主动脉内球囊反搏患者心脏移植。

Waitlist and post-transplant outcomes in patients listed with intra-aortic balloon pump for heart transplant: United Network for Organ Sharing registry.

机构信息

Department of Internal Medicine, Houston Methodist Hospital, Houston, TX, USA.

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, TX, USA.

出版信息

Int J Artif Organs. 2020 Sep;43(9):606-613. doi: 10.1177/0391398820903312. Epub 2020 Feb 21.

Abstract

BACKGROUND

Intra-aortic balloon pump as bridge-to-transplant (BTT) has been used successfully in patients with refractory cardiogenic shock. However, the waitlist mortality in this population is high and predictors of waitlist mortality in this population are not known. We sought to identify predictors for waitlist mortality in patients listed with intra-aortic balloon pump and risk factors for 1-year mortality after heart transplant in this population.

METHODS

We identified patients listed for heart transplantation with intra-aortic balloon pump in the United Network for Organ Sharing data set from 1994 to 2015. Univariable and multivariable Cox proportional hazards models were used to identify predictors of waitlist mortality and 1-year post-transplant mortality.

RESULTS

From 1945 patients listed with intra-aortic balloon pump, 67.5% (N = 1313) were alive at 1 year and waitlist mortality was 32.5% (N = 632). We found that higher pulmonary vascular resistance, need for inotropes, and need for mechanical ventilation were associated with higher waitlist mortality. Mechanical ventilation and dialysis prior to transplantation were important predictors of 1-year post-transplant mortality.

CONCLUSION

Predictors of mortality such as high pulmonary vascular resistance, dialysis dependence, inotrope, and ventilator dependence in patients listed with intra-aortic balloon pump can help us identify those patients that are at high risk of dying prior to a heart transplantation.

摘要

背景

主动脉内球囊泵作为桥接移植(BTT)已成功用于难治性心源性休克患者。然而,该人群的等待名单死亡率较高,且该人群的等待名单死亡率预测因素尚不清楚。我们旨在确定接受主动脉内球囊泵治疗的患者在等待名单上死亡的预测因素,以及该人群在心脏移植后 1 年死亡的危险因素。

方法

我们从 1994 年至 2015 年在美国器官共享网络数据集确定了接受主动脉内球囊泵治疗的心脏移植患者名单。使用单变量和多变量 Cox 比例风险模型来确定等待名单死亡率和移植后 1 年死亡率的预测因素。

结果

在接受主动脉内球囊泵治疗的 1945 名患者中,有 67.5%(N=1313)在 1 年内存活,等待名单死亡率为 32.5%(N=632)。我们发现,较高的肺血管阻力、需要使用正性肌力药和需要使用机械通气与较高的等待名单死亡率相关。移植前需要机械通气和透析是移植后 1 年死亡率的重要预测因素。

结论

在接受主动脉内球囊泵治疗的患者中,死亡率的预测因素如肺血管阻力高、依赖透析、使用正性肌力药和依赖呼吸机,可帮助我们识别那些在心脏移植前死亡风险较高的患者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验